The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.
Asialoglycoprotein receptor mediated hepatocyte targeting — Strategies and applications
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wiederschain, G. Y. (2009) · Biochemistry (Moscow) · doi:10.1134/s0006297909090156 · Cited by 4,083
Lavanchy, D. (2004) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00487.x · Cited by 2,642
Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.036 · Cited by 2,181
Nanocarriers’ entry into the cell: relevance to drug delivery
Hillaireau, H., & Couvreur, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0053-z · Cited by 1,552
Receptor-mediated in vitro gene transformation by a soluble DNA carrier system.
Wu, G. Y., & Wu, C. H. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61209-8 · Cited by 855
The asialoglycoprotein receptor: relationships between structure, function, and expression
Stockert, R. J. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.3.591 · Cited by 520
Age-related changes in liver structure and function: Implications for disease ?
Schmucker, D. L. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.06.009 · Cited by 481
Hepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
Seymour, L. W., Ferry, D. R., Anderson, D., Hesslewood, S., Julyan, P. J., Poyner, R., Doran, J., Young, A., Burtles, S. S., & Kerr, D. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1668 · Cited by 435
Preparation of alginate/galactosylated chitosan scaffold for hepatocyte attachment
Chung, T. W., Yang, J., Akaike, T., Cho, K. Y., Nah, J. W., Kim, S. I., & Cho, C. S. (2002) · Biomaterials · doi:10.1016/s0142-9612(01)00399-4 · Cited by 371
Schwartz, A. L., Fridovich, S. E., & Lodish, H. F. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34710-0 · Cited by 364
Powell, L. D., & Varki, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14243 · Cited by 312
Challenges in design and characterization of ligand-targeted drug delivery systems
Muro, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.052 · Cited by 307
Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting
Bhadra, D., Yadav, A. K., Bhadra, S., & Jain, N. K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.026 · Cited by 280
Human hepatic lectin. Physiochemical properties and specificity.
Baenziger, J. U., & Maynard, Y. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85538-2 · Cited by 264
Tanabe, T., Pricer, W. E., & Ashwell, G. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34164-9 · Cited by 261
Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier
Kim, T. H., Park, I. K., Nah, J. W., Choi, Y. J., & Cho, C. S. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.10.063 · Cited by 250
Recent Trends in Targeted Anticancer Prodrug and Conjugate Design
Singh, Y., Palombo, M., & Sinko, P. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708785132997 · Cited by 242
Agrawal, P., Gupta, U., & Jain, N. K. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.04.004 · Cited by 241
Wilson, J. M., Grossman, M., Wu, C. H., Chowdhury, N. R., Wu, G. Y., & Chowdhury, J. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48379-2 · Cited by 240
In Vitro Imaging and in Vivo Liver Targeting with Carbohydrate Capped Quantum Dots
Kikkeri, R., Lepenies, B., Adibekian, A., Laurino, P., & Seeberger, P. H. (2009) · Journal of the American Chemical Society · doi:10.1021/ja807711w · Cited by 233
Rensen, P. C. N., Sliedregt, L. A. J. M., Ferns, M., Kieviet, E., van Rossenberg, S. M. W., van Leeuwen, S. H., van Berkel, T. J. C., & Biessen, E. A. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101786200 · Cited by 231
Connolly, D. T., Townsend, R. R., Kawaguchi, K., Bell, W. R., & Lee, Y. C. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68290-6 · Cited by 224
Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting
Rensen, P. C. N., de Vrueh, R. L. A., Kuiper, J., Bijsterbosch, M. K., Biessen, E. A. L., & van Berkel, T. J. C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00109-0 · Cited by 215
Biochemistry of carbohydrate‐protein interaction 1
Lee, Y. C. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.13.1397841 · Cited by 209
Structural Basis of Galactose Recognition by C-type Animal Lectins
Kolatkar, A. R., & Weis, W. I. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.12.6679 · Cited by 207
Targeted nanoparticles for detecting and treating cancer
Sunderland, C. J., Steiert, M., Talmadge, J. E., Derfus, A. M., & Barry, S. E. (2006) · Drug Development Research · doi:10.1002/ddr.20069 · Cited by 200
Terada, T., Iwai, M., Kawakami, S., Yamashita, F., & Hashida, M. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.12.023 · Cited by 197
Targeting hepatocytes for drug and gene delivery emerging novel approaches and applications
Wu, J. (2002) · Frontiers in Bioscience · doi:10.2741/a806 · Cited by 190
Schwartz, A. L., Bolognesi, A., & Fridovich, S. E. (1984) · The Journal of cell biology · doi:10.1083/jcb.98.2.732 · Cited by 187
Julyan, P. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00124-2 · Cited by 180
クリノアタカマイトCu 2 (OH) 3 ClとテノライトCuOナノ粒子のpH制御選択合成
Engelbrekt, C., Phillip, M., Jonas, A., Lijuan, Z., Kenny, S., Li, B., Jun, H., & Zhang, J. (2014) · Cited by 180
Suriano, F., Pratt, R., Tan, J. P. K., Wiradharma, N., Nelson, A., Yang, Y.-Y., Dubois, P., & Hedrick, J. L. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.12.022 · Cited by 177
Evidence for receptor-mediated hepatic uptake of pullulan in rats
Kaneo, Y., Tanaka, T., Nakano, T., & Yamaguchi, Y. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00368-0 · Cited by 176
Galactose-carrying polymers as extracellular matrices for liver tissue engineering
Cho, C. S., Seo, S. J., Park, I. K., Kim, S. H., Kim, T. H., Hoshiba, T., Harada, I., & Akaike, T. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2005.06.008 · Cited by 174
Drug targeting to the diseased liver
Poelstra, K., Prakash, J., & Beljaars, L. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.011 · Cited by 172
Cell-specific delivery of genes with glycosylated carriers
HASHIDA, M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00209-5 · Cited by 171
Galactosylated chitosan as a synthetic extracellular matrix for hepatocytes attachment
Park, I.-K., Yang, J., Jeong, H.-J., Bom, H.-S., Harada, I., Akaike, T., Kim, S.-I., & Cho, C.-S. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00108-x · Cited by 163
Galactosylated chitosan–graft–dextran as hepatocyte-targeting DNA carrier
Park, Y. K., Park, Y. H., Shin, B. A., Choi, E. S., Park, Y. R., Akaike, T., & Cho, C. S. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00298-4 · Cited by 163
Xu, W., Cao, L., Chen, L., Li, J., Zhang, X.-F., Qian, H.-H., Kang, X.-Y., Zhang, Y., Liao, J., Shi, L.-H., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0498 · Cited by 161
Saunier, B., Triyatni, M., Ulianich, L., Maruvada, P., Yen, P. M., & Kohn, L. D. (2002) · Journal of Virology · doi:10.1128/jvi.77.1.546-559.2003 · Cited by 161
Chen, S., Tam, Y. Y. C., Lin, P. J. C., Leung, A. K. K., Tam, Y. K., & Cullis, P. R. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.025 · Cited by 160
Kunath, K., von Harpe, A., Fischer, D., & Kissel, T. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00458-3 · Cited by 159
Asialoglycoprotein Receptor-Mediated Gene Transfer Using Novel Galactosylated Cationic Liposomes
Kawakami, S., Yamashita, F., Nishikawa, M., Takakura, Y., & Hashida, M. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9602 · Cited by 159
Galactosylated fluorescent labeled micelles as a liver targeting drug carrier
Wu, D.-Q., Lu, B., Chang, C., Chen, C.-S., Wang, T., Zhang, Y.-Y., Cheng, S.-X., Jiang, X.-J., Zhang, X.-Z., & Zhuo, R.-X. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.11.027 · Cited by 158
Selim, K. M. K., Ha, Y.-S., Kim, S.-J., Chang, Y., Kim, T., Lee, G. H., & Kang, I. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.09.014 · Cited by 154
Galactosylated alginate as a scaffold for hepatocytes entrapment
Yang, J., Goto, M., Ise, H., Cho, C.-S., & Akaike, T. (2002) · Biomaterials · doi:10.1016/s0142-9612(01)00129-6 · Cited by 153
Synthesis of Cluster Galactosides with High Affinity for the Hepatic Asialoglycoprotein Receptor
Biessen, E. A. L., Beuting, D. M., Roelen, H. C. P. F., van der MAREL, G. A., BOOM, J. H. V., & van Berkel, T. J. C. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00009a014 · Cited by 151
Targeted delivery of plasmid DNA complexed with galactosylated poly(l-lysine)
Hashida, M., Takemura, S., Nishikawa, M., & Takakura, Y. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00263-0 · Cited by 150
Jiang, H., Kwon, J., Kim, E., Kim, Y.-K., Arote, R. B., Jere, D., Jeong, H., Jang, M.-K., Nah, J., Xu, C., et al. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.07.029 · Cited by 147
Varga, C. M., Wickham, T. J., & Lauffenburger, D. A. (2000) · Biotechnology and Bioengineering · doi:10.1002/1097-0290(20001220)70:6<593::aid-bit1>3.0.co;2-n · Cited by 146
Grewal, P. K. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(10)79013-3 · Cited by 143
Sliedregt, L. A. J. M., Rensen, P. C. N., Rump, E. T., van Santbrink, P. J., Bijsterbosch, M. K., Valentijn, A. R. P. M., van der MAREL, G. A., BOOM, J. H. V., van Berkel, T. J. C., & Biessen, E. A. L. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm981078h · Cited by 139
Nishikawa, M., Takemura, S., Takakura, Y., & Hashida, M. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37804-8 · Cited by 135
Hepatocyte Targeting and Intracellular Copper Chelation by a Thiol-Containing Glycocyclopeptide
Pujol, A. M., Cuillel, M., Renaudet, O., Lebrun, C., Charbonnier, P., Cassio, D., Gateau, C., Dumy, P., Mintz, E., & Delangle, P. (2010) · Journal of the American Chemical Society · doi:10.1021/ja106206z · Cited by 133
Kim, T. H., Kim, S. I., Akaike, T., et al. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.03.024 · Cited by 132
Seo, S.-J., Kim, I.-Y., Choi, Y., Akaike, T., & Cho, C. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.09.018 · Cited by 130
Galactose-Decorated pH-Responsive Nanogels for Hepatoma-Targeted Delivery of Oridonin
Duan, C., Gao, J. B., Zhang, D., Jia, L., Liu, Y., Zheng, D., Liu, G., Tian, X., Wang, F., & Zhang, Q. (2011) · Biomacromolecules · doi:10.1021/bm201270m · Cited by 130
Rice, K. G., Weisz, O. A., Barthel, T. K., Lee, R. T., & Lee, Y. C. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44770-3 · Cited by 128
A new synthesis of galactose-poly(ethylene glycol)-polyethylenimine for gene delivery to hepatocytes
SAGARA, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00555-7 · Cited by 127
Li, Y., Huang, G., Diakur, J. M., & Wiebe, L. I. (2008) · Current Drug Delivery · doi:10.2174/156720108785915069 · Cited by 125
Warren, R., & Doyle, D. J. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69971-0 · Cited by 124
Gotoh, Y., Niimi, S., Hayakawa, T., & Miyashita, T. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00633-1 · Cited by 124
Efficient Hepatic Delivery of Drugs: Novel Strategies and Their Significance
Mishra, N., Yadav, N. P., Kumar, V., Sinha, P., Yadav, K. S., Jain, S., & Arora, S. (2013) · BioMed Research International · doi:10.1155/2013/382184 · Cited by 123
(1999) · PubMed · Cited by 120
Zhong, Y., Yang, W., Sun, H., Cheng, R., Meng, F., Deng, C., & Zhong, Z. (2013) · Biomacromolecules · doi:10.1021/bm401098w · Cited by 119
Wakebayashi, D., Nishiyama, N., Yamasaki, Y., Itaka, K., Kanayama, N., Harada, A., Nagasaki, Y., & Kataoka, K. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.01.003 · Cited by 119
Hepatocellular carcinoma: Epidemiology and clinical aspects
Mazzanti, R., Gramantieri, L., & Bolondi, L. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.09.008 · Cited by 119
Targeting of lactosylceramide-containing liposomes to hepatocytes in vivo
Spanjer, H. H., & Scherphof, G. L. (1983) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(83)90072-x · Cited by 115
Yu, C., Wang, Y., Li, N., Liu, G.-S., Yang, S., Tang, G., He, D., Tan, X., & Wei, H. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400412c · Cited by 114
Liang, H., Yang, T.-F., Huang, C.-T., Chen, M., & Sung, H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.03.021 · Cited by 112
Liver targeting of plasmid DNA by pullulan conjugation based on metal coordination
Hosseinkhani, H., Aoyama, T., Ogawa, O., & Tabata, Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00201-8 · Cited by 112
N-acetylgalactosamine-functionalized dendrimers as hepatic cancer cell-targeted carriers
Medina, S. H., Tekumalla, V., Chevliakov, M. V., Shewach, D. S., Ensminger, W. D., & ElSayed, M. E. H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.068 · Cited by 112
A biocleavable pullulan-based vector via ATRP for liver cell-targeting gene delivery
Yang, X., Niu, Y.-L., Zhao, N., Mao, C., & Xu, F. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.036 · Cited by 111
Oishi, M., Nagatsugi, F., Sasaki, S., Nagasaki, Y., & Kataoka, K. (2005) · ChemBioChem · doi:10.1002/cbic.200400334 · Cited by 111
Nanocarriers Enhance Doxorubicin Uptake in Drug-Resistant Ovarian Cancer Cells
Arora, H., Jensen, M. P., Yuan, Y., Wu, A., Vogt, S., Paunesku, T., & Woloschak, G. E. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2890 · Cited by 109
Katō, Y., Onishi, H., & Machida, Y. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00356-4 · Cited by 107
Chen, W., Zou, Y., Meng, F., Cheng, R., Deng, C., Feijén, J., & Zhong, Z. (2014) · Biomacromolecules · doi:10.1021/bm401749t · Cited by 100
Mechanism of N-Acetylgalactosamine Binding to a C-type Animal Lectin Carbohydrate-recognition Domain
Kolatkar, A. R., Leung, A. K. L., Isecke, R., Brossmer, R., Drickamer, K., & Weis, W. I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.31.19502 · Cited by 97
Biochemical and molecular aspects of genetic disorders of bilirubin metabolism
Iyanagi, T., Emi, Y., & Ikushiro, S. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(98)00044-1 · Cited by 96
Treré, D., FIUME, L., Giorgi, L. B. D., Stefano, G. D., Migaldi, M., & Derenzini, M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690708 · Cited by 95
Arima, H., Yamashita, S., Mori, Y., Hayashi, Y., Motoyama, K., Hattori, K., Takeuchi, T., Jono, H., Ando, Y., Hirayama, F., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.05.030 · Cited by 95
Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma
Lee, R. J., Lee, R. J., Zhang, Yung, Li, Zhou, C., & Lee, L. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s33965 · Cited by 94
Managit, C., Kawakami, S., Yamashita, F., & Hashida, M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20443 · Cited by 93
Merwin, J. R., Noell, G. S., Thomas, W. L., Chiou, H. C., DeRome, M., McKee, T. D., Spitalny, G. L., & Findeis, M. A. (1994) · Bioconjugate Chemistry · doi:10.1021/bc00030a017 · Cited by 93
Zhang, M., Zhou, X., Wang, B., Yung, B. C., Lee, L. J., Ghoshal, K., & Lee, R. J. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.03.020 · Cited by 93
Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery
Wang, Q., Zhang, L., Hu, W., Hu, Z., Bei, Y.-Y., Xu, J.-Y., Wang, W., Zhang, X.-N., & Zhang, Q. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.07.006 · Cited by 91
Targeted Delivery of siRNA to Hepatocytes and Hepatic Stellate Cells by Bioconjugation
Zhu, L., & Mahato, R. I. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100346n · Cited by 91
Zou, Y., Song, Y., Yang, W., Meng, F., Liu, H., & Zhong, Z. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.016 · Cited by 90
Wang, H., Xiong, M., Wang, Y., Zhu, J., & Wang, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.12.017 · Cited by 90
High drug loading pH-sensitive pullulan-DOX conjugate nanoparticles for hepatic targeting
Li, H., Bian, S., Huang, Y., Liang, J., Fan, Y., & Zhang, X. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34680 · Cited by 89
Asialoglycoprotein receptor (ASGPR): a peculiar target of liver-specific autoimmunity
Roggenbuck, D., Mytilinaiou, M. G., Lapin, S. V., Reinhold, D., & Conrad, K. (2012) · Autoimmunity Highlights · doi:10.1007/s13317-012-0041-4 · Cited by 86
Rat hepatocytes bind to synthetic galactoside surfaces via a patch of asialoglycoprotein receptors.
Weigel, P. H. (1980) · The Journal of Cell Biology · doi:10.1083/jcb.87.3.855 · Cited by 86
Ding, J., Xiao, C., Li, Y., Cheng, Y., Wang, N., He, C., Zhuang, X., Zhu, X., & Chen, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.12.006 · Cited by 85
Galactosylated polyethylenimine-graft-poly(vinyl pyrrolidone) as a hepatocyte-targeting gene carrier
Cook, S. E., Park, I., Kim, E. M., Jeong, H. J., Park, T. G., Choi, Y. J., Akaike, T., & Cho, C. S. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.03.011 · Cited by 85
Shimada, K., Kamps, J. A. A. M., Regts, J., Ikeda, K., Shiozawa, T., Hirota, S., & Scherphof, G. L. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00036-9 · Cited by 84
A galactosamine-mediated drug delivery carrier for targeted liver cancer therapy
Shen, Z., Wei, W., Tanaka, H., Kohama, K., Ma, G., Dobashi, T., Maki, Y., Wang, H., Bi, J., & Dai, S. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.06.015 · Cited by 83
Rd, C., & Schnaar, L. R. (2009) · Europe PMC (PubMed Central) · Cited by 82
Popielarski, S. R., Pun, S. H., & Davis, M. E. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050113d · Cited by 81
Longmuir, K. J., Robertson, R. T., Haynes, S. M., Baratta, J. L., & Waring, A. J. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9609-x · Cited by 80
Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes
Arangoa, M. A., Düzgüneş, N., & de Ilarduya, C. T. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301840 · Cited by 80
Glycosylation-mediated targeting of carriers
Kawakami, S., & Hashida, M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.001 · Cited by 78
Endocytosis via galactose receptors in vivo
Schlepper‐Schäfer, J., Hülsmann, D., Djovkar, A., Meyer, H. E., Herbertz, L., Kolb, H., & Kolb-Bachofen, V. (1986) · Experimental Cell Research · doi:10.1016/0014-4827(86)90602-6 · Cited by 76
Polyethylene sebacate–doxorubicin nanoparticles for hepatic targeting
Guhagarkar, S. A., Gaikwad, R. V., Samad, A., Malshe, V. C., & Devarajan, P. V. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.09.012 · Cited by 75
Self-citationWang, S., Deng, Y., Xu, H., Wu, H., QIU, Y., & CHEN, D. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.07.004 · Cited by 74
Harris, R., van den Berg, C. W., & Bowen, D. J. (2012) · Molecular Biology International · doi:10.1155/2012/283974 · Cited by 72
Hopewell, J. W., Duncan, R., Wilding, D., & Chakrabarti, K. (2001) · Human & Experimental Toxicology · doi:10.1191/096032701682693017 · Cited by 72
Beuth, J., Ko, H. L., Oette, K., Pulverer, G., Roszkowski, K., & Uhlenbruck, G. (1987) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf00389966 · Cited by 70
Pharmacokinetics of receptor-mediated hepatic uptake of glycosylated albumin in mice
Nishikawa, M., Ohtsubo, Y., Ohno, J., Fujita, T., Koyama, Y., Yamashita, F., Hashida, M., & Sezaki, H. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90136-p · Cited by 70
Sun, P., He, Y., Lin, M., Zhao, Y., Ding, Y., Chen, G., & Jiang, M. (2013) · ACS Macro Letters · doi:10.1021/mz400577p · Cited by 70
Cho, C. S., Cho, K. Y., Park, I. K., Kim, S. H., Sasagawa, T., Uchiyama, M., & Akaike, T. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00390-x · Cited by 68
Targeted and sustained drug delivery using PEGylated galactosylated liposomes
Managit, C., Kawakami, S., Nishikawa, M., Yamashita, F., & Hashida, M. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00383-1 · Cited by 68
FIUME, L., Mattioli, A., Balboni, P. G., Tognon, M. G., Barbanti-Brodano, G., Vries, J. D., & Wieland, T. (1979) · FEBS Letters · doi:10.1016/0014-5793(79)81247-8 · Cited by 66
The Adaptive Response of the Reticuloendothelial System to Major Liver Resection in Humans
Schindl, M., Millar, A. M., Redhead, D. N., Fearon, K. C. H., Ross, J. A., Dejong, C. H. C., Garden, O. J., & Wigmore, S. J. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000205826.62911.a7 · Cited by 66
Maruyama, K., Iwasaki, F., 知子, 滝., Yanagië, H., Niidome, T., Yamada, E., Ito, T., & Koyama, Y. (2003) · Biomaterials · doi:10.1016/j.biomaterials.2003.10.004 · Cited by 65
High density of immobilized galactose ligand enhances hepatocyte attachment and function
Yin, C., Ying, L., Zhang, P., Zhuo, R., Kang, E. T., Leong, K. W., & Mao, H. (2003) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.10033 · Cited by 65
Seo, S.-J., Akaike, T., Choi, Y., Shirakawa, M., Kang, I., & Cho, C. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.09.025 · Cited by 62
Mukthavaram, R., Marepally, S. K., Mahidhar, Y. V., Vegi, G. N., Sistla, R., & Chaudhuri, A. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.074 · Cited by 61
Capturing circulating tumor cells of hepatocellular carcinoma
Wu, L., Pan, Y., Pei, X., Chen, H., Nguyen, S., Kashyap, A., Liu, J., & Wu, J. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.07.024 · Cited by 60
Targeting Efficiency of Galactosylated Liposomes to Hepatocytes in Vivo: Effect of Lipid Composition
Murao, A., Nishikawa, M., Managit, C., Wong, J., Kawakami, S., Yamashita, F., & Hashida, M. (2002) · Pharmaceutical Research · doi:10.1023/a:1021433206081 · Cited by 59
Villa, R., Cerroni, B., Viganò, L., Margheritelli, S., Abolafio, G., Oddo, L., Paradossi, G., & Zaffaroni, N. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.04.022 · Cited by 57
Design, synthesis and evaluation of monovalent ligands for the asialoglycoprotein receptor (ASGP-R)
Stokmaier, D., Khorev, O., Cutting, B., Born, R., Ricklin, D., Ernst, T. O. G., Boeni, F., Schwingruber, K., Gentner, M., Wittwer, M., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.08.049 · Cited by 56
Hirabayashi, H., Nishikawa, M., Takakura, Y., & Hashida, M. (1996) · Pharmaceutical Research · doi:10.1023/a:1016053128569 · Cited by 55
Franssen, E. J. F., Jansen, R. W., Vaalburg, M., & Meijer, D. K. F. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90273-y · Cited by 55
Wei, W., Yue, Z., Qu, J., Yue, H., Su, Z. G., & Ma, G. (2010) · Nanomedicine · doi:10.2217/nnm.10.27 · Cited by 55
Jo, J.-I., Ikai, T., Okazaki, A., Yamamoto, M., Hirano, Y., & Tabata, Y. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.01.005 · Cited by 53
Galactosylated solid lipid nanoparticles with cucurbitacin B improves the liver targetability
Wang, W., Zhao, X., Hu, H., Chen, D., Gu, J.-C., Deng, Y., & Sun, J. (2010) · Drug Delivery · doi:10.3109/10717540903580176 · Cited by 52
Targeted delivery of drugs and proteins to the liver via receptor-mediated endocytosis
Hashida, M., Hirabayashi, H., Nishikawa, M., & Takakura, Y. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01577-5 · Cited by 51
Ribavirin conjugated with lactosaminated poly-l-lysine
Stefano, G. D., Colonna, F. P., Bongini, A., Busi, C., Mattioli, A., & FIUME, L. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00223-2 · Cited by 51
Han, J.-H., Oh, Y., Kim, D., & Kim, C. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00206-9 · Cited by 50
Singh, M., & Ariatti, M. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00360-2 · Cited by 49
Yumoto, Y., Yagi, T., Sato, S., et al. (2010) · British journal of surgery · doi:10.1002/bjs.7025 · Cited by 47
Liver targeting of antiviral nucleoside analogues through the asialoglycoprotein receptor
FIUME, L., Stefano, G. D., Busi, C., Mattioli, A., Bonino, F., Torrani-Cerenzia, M. R., Verme, G., Rapicetta, M., Bertini, M., & Gervasi, G. B. (1997) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1997.00067.x · Cited by 47
Peng, J., Wang, K., Tan, W.-H., He, X., He, C., Wu, P., & Liu, F. (2006) · Talanta · doi:10.1016/j.talanta.2006.05.064 · Cited by 46
Galactose-Modified Cationic Liposomes as a Liver-Targeting Delivery System for Small Interfering RNA
Sonoke, S., Ueda, T., Fujiwara, K., Kuwabara, K., & Yano, J. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1338 · Cited by 46
Soenen, S. J., Brisson, A. R., Jonckheere, E., Nuytten, N., Tan, S., Himmelreich, U., & Cuyper, M. D. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.005 · Cited by 45
Targeted gene delivery to hepatocytes with galactosylated amphiphilic cyclodextrins
Mcmahon, A., O’Neill, M. J., Gómez‐Orte, E., Donohue, R., Forde, D., Darcy, R., & O’Driscoll, C. M. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01497.x · Cited by 44
Zhang, Y., Qi, X., Gao, Y., et al. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.11.006 · Cited by 44
Preparation of Asialoorosomucoid-Polylysine Conjugates
McKee, T. D., DeRome, M., Wu, G. Y., & Findeis, M. A. (1994) · Bioconjugate Chemistry · doi:10.1021/bc00028a004 · Cited by 44
Galactosylated Micelles for a Ribavirin Prodrug Targeting to Hepatocytes
Craparo, E. F., Triolo, D., Pitarresi, G. L., Giammona, G., & Cavallaro, G. (2013) · Biomacromolecules · doi:10.1021/bm4002409 · Cited by 44
Zhang, X. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30034 · Cited by 43
Westerlind, U., Westman, J., Törnquist, E., Smith, C. I. E., Oscarson, S., Lahmann, M., & Norberg, T. (2004) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000045095.86867.c0 · Cited by 42
Drug delivery using vesicles targeted to the hepatic asialoglycoprotein receptor
Dragsten, P. R., Mitchell, D. B., Covert, G., & Baker, T. (1987) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(87)90213-3 · Cited by 41
Kim, I., & Kim, S. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00128-5 · Cited by 41
Yoshida, M., Shiraishi, S., Sakaguchi, F., Utsunomiya, D., Tashiro, K., Tomiguchi, S., Okabe, H., Beppu, T., Baba, H., & Yamashita, Y. (2012) · Japanese Journal of Radiology · doi:10.1007/s11604-011-0041-8 · Cited by 40
D’souza, A. A., Jain, P. P., Galdhar, C. N., Samad, A., Degani, M. S., & Devarajan, P. V. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9474-6 · Cited by 40
Self-citationLactoferrin binding to the rat asialoglycoprotein receptor requires the receptor's lectin properties
McAbee, D. D., JIANG, X., & Walsh, K. B. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3480113 · Cited by 40
Biessen, E. A. L., Beuting, D. M., Vietsch, H., Bijsterbosch, M. K., & van Berkel, T. J. C. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(94)80243-2 · Cited by 40
Onizuka, T., Shimizu, H., Moriwaki, Y., Nakano, T., Kanai, S., Shimada, I., & Takahashi, H. K. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08643.x · Cited by 39
Characterization of the interaction of galactose-exposing particles with rat Kupffer cells
Kuiper, J., Bakkeren, H. F., Biessen, E. A. L., & van Berkel, T. J. C. (1994) · Biochemical Journal · doi:10.1042/bj2990285 · Cited by 39
Synthesis of multifunctional chitosan with galactose as a targeting ligand for glycoprotein receptor
Lin, L., & Chen, M. H. (2006) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2006.06.017 · Cited by 39
Uptake of lactosylated low-density lipoprotein by galactose-specific receptors in rat liver
Bijsterbosch, M. K., & van Berkel, T. J. C. (1990) · Biochemical Journal · doi:10.1042/bj2700233 · Cited by 39
Differential ligand binding by two subunits of the rat liver asialoglycoprotein receptor
Ruiz, N. I., & Drickamer, K. (1996) · Glycobiology · doi:10.1093/glycob/6.5.551 · Cited by 38
Photodynamic therapy of fullerene modified with pullulan on hepatoma cells
Liu, J., & Tabata, Y. (2010) · Journal of drug targeting · doi:10.3109/10611861003599479 · Cited by 38
Díaz, C., Vargas-Méndez, E., & Gätjens-Boniche, O. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.06.034 · Cited by 35
Development of Cell-Specific Targeting Systems for Drugs and Genes
Nishikawa, M. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.195 · Cited by 35
Rotundo, R. F., Rebres, R. A., McKeown‐Longo, P. J., Blumenstock, F. A., & Saba, T. M. (1998) · Hepatology · doi:10.1002/hep.510280227 · Cited by 35
Tao, Y., He, J., Zhang, M., Hao, Y., Liu, J., & Ni, P. (2014) · Polymer Chemistry · doi:10.1039/c4py00024b · Cited by 34
Maitani, Y., Kawano, K., Yamada, K., Nagai, T., & Takayama, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00411-4 · Cited by 34
Conjugates of Ara-AMP with Lactosaminated Albumin: A Study on Their Immunogenicity in Mouse and Rat
FIUME, L., BUSl, C., PRETI, P., & Spinosa, G. (1987) · Cancer Drug Delivery · doi:10.1089/cdd.1987.4.145 · Cited by 33
Targeting of antiviral drugs to the liver using glycoprotein carriers
FIUME, L., Busi, C., Stefano, G. D., & Mattioli, A. (1994) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(94)90005-1 · Cited by 32
Wang, S., Cheng, L., Yu, F., Pan, W., & Zhang, J. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.12.014 · Cited by 31
Targeting of Soybean-Derived Sterylglucoside Liposomes to Liver Tumors in Rat and Mouse Models.
Shimizu, K., Qi, X., Maitani, Y., YOSHII, M., Kawano, K., Takayama, K., & Nagai, T. (1998) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.21.741 · Cited by 30
Li, X., Wu, Q., Chen, Z., Gong, X., & Lin, X. (2008) · Polymer · doi:10.1016/j.polymer.2008.09.006 · Cited by 28
Ong, Z. Y., Yang, C. H., Gao, S. J., Ke, X., Hedrick, J. L., & Yang, Y. Y. (2013) · Macromolecular Rapid Communications · doi:10.1002/marc.201300538 · Cited by 28
Akamatsu, K., Yamasaki, Y., Nishikawa, M., Takakura, Y., & Hashida, M. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35028-1 · Cited by 27
Guhagarkar, S. A., Majee, S. B., Samad, A., & Devarajan, P. V. (2011) · Cancer Nanotechnology · doi:10.1007/s12645-011-0012-x · Cited by 26
Self-citationDisposition Characteristics of Glycosylated Poly(amino acids) as Liver Cell-Specific Drug Carrier
Akamatsu, K., Imai, M., Yamasaki, Y., Nishikawa, M., Takakura, Y., & Hashida, M. (1998) · Journal of drug targeting · doi:10.3109/10611869808997897 · Cited by 26
Potential Use of Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for siRNA
Arima, H., Motoyama, K., & Higashi, T. (2011) · Pharmaceuticals · doi:10.3390/ph5010061 · Cited by 25
Hayashi, Y., Higashi, T., Motoyama, K., Mori, Y., Jono, H., Ando, Y., & Arima, H. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2013.769105 · Cited by 24
Cho, H.-A., Park, I.-S., Kim, T., Oh, Y., Yang, K., & Kim, J. S. (2009) · Archives of Pharmacal Research · doi:10.1007/s12272-009-1714-z · Cited by 24
Hepatocyte transplantation for total liver repopulation
Mizuguchi, T., Mitaka, T., Katsuramaki, T., & Hirata, K. (2005) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-005-0986-z · Cited by 23
Cellular disposition of arabinogalactan in primary cultured rat hepatocytes
Tanaka, T., Fujishima, Y., Hamano, S., & Kaneo, Y. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.04.014 · Cited by 23
Štaud, F. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(99)00031-8 · Cited by 21
Yang, S., Heo, D., Lee, E., Kim, E., Lim, E., Lee, Y. H., Haam, S., Suh, J., Huh, Y., Yang, J., et al. (2013) · Nanotechnology · doi:10.1088/0957-4484/24/47/475103 · Cited by 20
α3‐Galactosylated glycoproteins can bind to the hepaticasialoglycoprotein receptor
Joziasse, D. H., Lee, R. T., Lee, Y. C., Biessen, E. A. L., Schiphorst, W. E. C. M., Koeleman, C. A. M., & EIJNDEN, D. H. V. D. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01747.x · Cited by 19
Ishihara, T., Kano, A., Obara, K., Saito, M., Chen, X., Park, T. G., Akaike, T., & Maruyama, A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.014 · Cited by 19
Biessen, E. A. L., Vietsch, H., & van Berkel, T. J. C. (1994) · Biochemical Journal · doi:10.1042/bj3020283 · Cited by 19
Ramadugu, S. K., Chung, Y., Fuentes, E. J., Rice, K. G., & Margulis, C. J. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1021766 · Cited by 18
Lactosaminated-N-succinyl chitosan nanoparticles for hepatocyte-targeted delivery of acyclovir
Jain, N., Rajoriya, V., Jain, P. K., & Jain, A. K. (2013) · Journal of Nanoparticle Research · doi:10.1007/s11051-013-2136-x · Cited by 18
Novel galactosylated SLN for hepatocyte-selective targeting of floxuridinyl diacetate
Lian, J.-F., Zhang, S., Wang, J., Fang, K., Zhang, Y., & Hao, Y. (2008) · Journal of drug targeting · doi:10.1080/10611860801902351 · Cited by 16
Ma, J., Huang, C., XinXin, Y., Shi, C., Sun, L., Yuan, L., Lei, P., Zhu, H., Liu, H., Wu, X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046096 · Cited by 13
Hu, H., Zhang, X., Zhong, N.-Q., & Pan, S. (2012) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/092050611x558297 · Cited by 12
Phorbol ester‐induced redistribution of the ASGP receptor is independent of receptor phosphorylation
Geffen, I., & Spiess, M. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80669-8 · Cited by 5
Research works printed but not linked: 62
- Dodeur, 1982, Effects of streptozotocin-induced diabetes mellitus on the binding and uptake of asialoorosomucoid by isolated hepatocytes from rats, Eur. J. Biochem., 123, 383, 10.1111/j.1432-1033.1982.tb19780.x · doi:10.1111/j.1432-1033.1982.tb19780.x
- Kawakami, 2002, Glycosylated cationic liposomes for cell-selective gene delivery, Crit. Rev. Ther. Drug Carrier Syst., 19, 171, 10.1615/CritRevTherDrugCarrierSyst.v19.i2.30 · doi:10.1615/critrevtherdrugcarriersyst.v19.i2.30
- Wong, 1987, Synthesis of D-galactosamine derivatives and binding studies using isolated rat hepatocytes, Carbohydr. Res., 170, 27, 10.1016/0008-6215(87)85003-6 · doi:10.1016/0008-6215(87)85003-6
- Lee, 2011, New and more efficient multivalent glyco-ligands for asialoglycoprotein receptor of mammalian hepatocytes, Bioorg. Med. Chem., 19, 2494, 10.1016/j.bmc.2011.03.027 · doi:10.1016/j.bmc.2011.03.027
- McAbee, 1999, Copper and zinc ions differentially block asialoglycoprotein receptor-mediated endocytosis in isolated rat hepatocytes, J. Biol. Chem., 274, 14750, 10.1074/jbc.274.21.14750 · doi:10.1074/jbc.274.21.14750
- Kim, 2006, Asialoglycoprotein-receptor-targeted hepatocyte imaging using 99mTc galactosylated chitosan, Nucl. Med. Biol., 33, 529, 10.1016/j.nucmedbio.2006.03.005 · doi:10.1016/j.nucmedbio.2006.03.005
- Debanne, 1982, Receptor-rich intracellular membrane vesicles transporting asialotransferrin and insulin in liver, Nature, 298, 398, 10.1038/298398a0 · doi:10.1038/298398a0
- Fiume, 1997, Hepatotropic conjugate of adenine arabinoside monophosphate with lactosaminated poly-ʟ-lysine. Synthesis of the carrier and pharmacological properties of the conjugate, J. Hepatol., 26, 253, 10.1016/S0168-8278(97)80038-4 · doi:10.1016/s0168-8278(97)80038-4
- Regoeczi, 1978, Elimination of asialofetuin and asialoorosomucoid by the intact rat. Quantitative aspects of the hepatic clearance mechanism, Biochim. Biophys. Acta, 541, 372, 10.1016/0304-4165(78)90196-4 · doi:10.1016/0304-4165(78)90196-4
- Kaneo, 2000, Pharmacokinetics and biodisposition of fluorescein-labeled arabinogalactan in rats, Int. J. Pharm., 201, 59, 10.1016/S0378-5173(00)00405-1 · doi:10.1016/s0378-5173(00)00405-1
- Bertoldo, 2004, Cloning, sequencing, and characterization of a heat- and alkali-stable type I pullulanase from Anaerobranca gottschalkii, Appl. Environ. Microbiol., 70, 3407, 10.1128/AEM.70.6.3407-3416.2004 · doi:10.1128/aem.70.6.3407-3416.2004
- Gupta, 2004, In vitro cytotoxicity studies of hydrogel pullulan nanoparticles prepared by AOT/N-hexane micellar system, J. Pharm. Pharm. Sci., 7, 38
- Tanaka, 2005, Uptake of pullulan in cultured rat liver parenchymal cells, Biol. Pharm. Bull., 28, 560, 10.1248/bpb.28.560 · doi:10.1248/bpb.28.560
- San Juan, 2007, Cationized pullulan 3D matrices as new materials for gene transfer, J. Biomed. Mater. Res. A, 82, 354, 10.1002/jbm.a.31062 · doi:10.1002/jbm.a.31062
- Yim, 2011, The performance of gadolinium diethylene triamine pentaacetate-pullulan hepatocyte-specific T1 contrast agent for MRI, Biomaterials, 32, 5187, 10.1016/j.biomaterials.2011.03.069 · doi:10.1016/j.biomaterials.2011.03.069
- Shimizu, 1997, Formulation of liposomes with a soybean-derived sterylglucoside mixture and cholesterol for liver targeting, Biol. Pharm. Bull., 20, 881, 10.1248/bpb.20.881 · doi:10.1248/bpb.20.881
- Ghiamkazemi, 2010, Synthesis, and characterization, and evaluation of cellular effects of the FOL-PEG-g-PEI-GAL nanoparticles as a potential non-viral vector for gene delivery, J. Nanomater., 10
- Meng, 2005, Immobilization of lactobionic acid on polyurethane films and their interaction with hepatocytes, Macromol. Res., 13, 257, 10.1007/BF03219061 · doi:10.1007/bf03219061
- Qin, 2011, Galactosylated N-2-hydroxypropyl methacrylamide-b-N-3-guanidinopropyl methacrylamide block copolymers as hepatocyte-targeting gene carriers, Bioconjug. Chem., 22, 1503, 10.1021/bc100525y · doi:10.1021/bc100525y
- Shigeta, 2007, Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG2 cells, J. Control. Release, 118, 262, 10.1016/j.jconrel.2006.12.019 · doi:10.1016/j.jconrel.2006.12.019
- Suginoshita, 2002, Liver targeting of human interferon-beta with pullulan based on metal coordination, J. Control. Release, 83, 75, 10.1016/S0168-3659(02)00197-9 · doi:10.1016/s0168-3659(02)00197-9
- Di Stefano, 2000, Enhanced liver blood concentrations of adenine arabinoside accomplished by lactosaminated poly-ʟ-lysine coupling: implications for regional chemotherapy of hepatic micrometastases, Biochem. Pharmacol., 59, 301, 10.1016/S0006-2952(99)00327-5 · doi:10.1016/s0006-2952(99)00327-5
- Peng, 2007, Inhibition of hepatocarcinoma by systemic delivery of apoptin gene via the hepatic asialoglycoprotein receptor, Cancer Gene Ther., 14, 66, 10.1038/sj.cgt.7700985 · doi:10.1038/sj.cgt.7700985
- Tomiya, 2013, Liver-targeting of primaquine-(poly-gamma-glutamic acid) and its degradation in rat hepatocytes, Bioorg. Med. Chem., 21, 5275, 10.1016/j.bmc.2013.06.028 · doi:10.1016/j.bmc.2013.06.028
- Fiume, 1984, Selective penetration and pharmacological activity of lactosaminated albumin conjugates of adenine arabinoside 5-monophosphate (ara-AMP) in mouse liver, Gut, 25, 1392, 10.1136/gut.25.12.1392 · doi:10.1136/gut.25.12.1392
- Naicker, 2014, PEGylated galactosylated cationic liposomes for hepatocytic gene delivery, Colloids Surf. B: Biointerfaces, 122, 482, 10.1016/j.colsurfb.2014.07.010 · doi:10.1016/j.colsurfb.2014.07.010
- Weigel, 1980, Characterization of the asialoglycoprotein receptor on isolated rat hepatocytes, J. Biol. Chem., 255, 6111, 10.1016/S0021-9258(18)43708-8 · doi:10.1016/s0021-9258(18)43708-8
- Kawakami, 2001, Novel galactosylated liposomes for hepatocyte-selective targeting of lipophilic drugs, J. Pharm. Sci., 90, 105, 10.1002/1520-6017(200102)90:2<105::AID-JPS1>3.0.CO;2-1 · doi:10.1002/1520-6017(200102)90:2<105::aid-jps1>3.0.co;2-1
- Hara, 1996, Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes, Biochim. Biophys. Acta, 1278, 51, 10.1016/0005-2736(95)00205-7 · doi:10.1016/0005-2736(95)00205-7
- Tep, 2009, Formulation and evaluation of ATP-containing liposomes including lactosylated ASGPr ligand, J. Liposome Res., 19, 287, 10.3109/08982100902838682 · doi:10.3109/08982100902838682
- Hai, 2010, Synthesis of multivalent galactosides as targeting ligand for gene delivery, Synth. Commun., 40, 1802, 10.1080/00397910903161827 · doi:10.1080/00397910903161827
- Narainpersad, 2012, Novel neo glycolipid: formulation into pegylated cationic liposomes and targeting of DNA lipoplexes to the hepatocyte-derived cell line HepG2, Nucleosides Nucleotides Nucleic Acids, 31, 206, 10.1080/15257770.2011.649331 · doi:10.1080/15257770.2011.649331
- Sun, 2005, Targeted gene delivery to hepatoma cells using galactosylated liposome-polycation-DNA complexes (LPD), J. Drug Target., 13, 121, 10.1080/10611860400024714 · doi:10.1080/10611860400024714
- Zhu, 2013, Galactosylated chitosan oligosaccharide nanoparticles for hepatocellular carcinoma cell-targeted delivery of adenosine triphosphate, Int. J. Mol. Sci., 14, 15755, 10.3390/ijms140815755 · doi:10.3390/ijms140815755
- Jain, 2010, Development and in vitro characterization of galactosylated low molecular weight chitosan nanoparticles bearing doxorubicin, AAPS PharmSciTech, 11, 686, 10.1208/s12249-010-9422-z · doi:10.1208/s12249-010-9422-z
- Varshosaz, 2012, Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma, J. Liposome Res., 22, 224, 10.3109/08982104.2012.662653 · doi:10.3109/08982104.2012.662653
- Lu, 2008, The use of solid lipid nanoparticles to target a lipophilic molecule to the liver after intravenous administration to mice, Int. J. Biol. Macromol., 43, 320, 10.1016/j.ijbiomac.2008.06.006 · doi:10.1016/j.ijbiomac.2008.06.006
- Joshi, 2014, Receptor-mediated hepatocyte-targeted delivery of primaquine phosphate nanocarboplex using a carbohydrate ligand, Drug Deliv. Transl. Res., 4, 353, 10.1007/s13346-014-0200-4 · doi:10.1007/s13346-014-0200-4
- Managit, 2005, Uptake characteristics of galactosylated emulsion by HepG2 hepatoma cells, Int. J. Pharm., 301, 255, 10.1016/j.ijpharm.2005.05.020 · doi:10.1016/j.ijpharm.2005.05.020
- Hattori, 2000, Controlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targeting, J. Control. Release, 69, 369, 10.1016/S0168-3659(00)00338-2 · doi:10.1016/s0168-3659(00)00338-2
- Ishida, 2004, Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice, Pharm. Res., 21, 932, 10.1023/B:PHAM.0000029280.39882.ff · doi:10.1023/b:pham.0000029280.39882.ff
- Motoyama, 2011, In vitro gene delivery mediated by lactosylated dendrimer (generation 3, G3)/α-cyclodextrin conjugates into hepatocytes, J. Incl. Phenom. Macrocycl. Chem., 70, 333, 10.1007/s10847-010-9842-0 · doi:10.1007/s10847-010-9842-0
- Wang, 2009, Long-term reduction of jaundice in Gunn rats by nonviral liver-targeted delivery of Sleeping Beauty transposon, Hepatology, 50, 815, 10.1002/hep.23060 · doi:10.1002/hep.23060
- Hohokabe, 2007, Hepatocyte-selective gene transfer by galactosylated protein/linear polyethyleneimine/plasmid DNA complexes in mice, J. Biomed. Nanotechnol., 3, 277, 10.1166/jbn.2007.034 · doi:10.1166/jbn.2007.034
- Hwang, 1999, Preoperative assessment of residual hepatic functional reserve using 99mTc-DTPA-galactosyl-human serum albumin dynamic SPECT, J. Nucl. Med., 40, 1644
- Iimuro, 2010, Preoperative estimation of asialoglycoprotein receptor expression in the remnant liver from CT/99mTc-GSA SPECT fusion images correlates well with postoperative liver function parameters, J. Hepatobiliary Pancreat. Sci., 17, 673, 10.1007/s00534-010-0264-6 · doi:10.1007/s00534-010-0264-6
- Kaibori, 2011, Usefulness of Tc-99m-GSA scintigraphy for liver surgery, Ann. Nucl. Med., 25, 593, 10.1007/s12149-011-0520-0 · doi:10.1007/s12149-011-0520-0
- Haubner, 2013, Development of (6)(8)Ga-labelled DTPA galactosyl human serum albumin for liver function imaging, Eur. J. Nucl. Med. Mol. Imaging, 40, 1245, 10.1007/s00259-013-2397-8 · doi:10.1007/s00259-013-2397-8
- Yoshinori, 2010, Molecular imaging contrast media for visualization of liver function, Magn. Reson. Imaging, 28, 708, 10.1016/j.mri.2010.02.003 · doi:10.1016/j.mri.2010.02.003
- Deal, 1998, Cellular distribution of 111In-LDTPA galactose BSA in normal and asialoglycoprotein receptor-deficient mouse liver, Nucl. Med. Biol., 25, 379, 10.1016/S0969-8051(97)00222-9 · doi:10.1016/s0969-8051(97)00222-9
- Ogawara, 1998, Pharmacokinetic analysis of hepatic uptake of galactosylated bovine serum albumin in a perfused rat liver, J. Control. Release, 50, 309, 10.1016/S0168-3659(97)00157-0 · doi:10.1016/s0168-3659(97)00157-0
- Ha-Kawa, 1997, Compartmental analysis of asialoglycoprotein receptor scintigraphy for quantitative measurement of liver function: a multicentre study, Eur. J. Nucl. Med., 24, 130, 10.1007/BF02439544 · doi:10.1007/bf02439544
- Yang, 2013, The preparation of 99mTc-DTPA-LSA and its instant lyophilized kit for hepatic receptor imaging, Appl. Radiat. Isot., 74, 1, 10.1016/j.apradiso.2012.12.009 · doi:10.1016/j.apradiso.2012.12.009
- Richard, 2009, Amphiphilic perfluoroalkyl carbohydrates as new tools for liver imaging, Int. J. Pharm., 379, 301, 10.1016/j.ijpharm.2009.05.045 · doi:10.1016/j.ijpharm.2009.05.045
- Ketkar-Atre, 2014, In vivo hepatocyte MR imaging using lactose functionalized magnetoliposomes, Biomaterials, 35, 1015, 10.1016/j.biomaterials.2013.10.029 · doi:10.1016/j.biomaterials.2013.10.029
- Hausdorf, 2009, Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA—revival of a disease-activity marker in autoimmune hepatitis, Clin. Chim. Acta, 408, 19, 10.1016/j.cca.2009.06.035 · doi:10.1016/j.cca.2009.06.035
- Ise, 2001, Separation of mouse hepatocytes of distinct biological phenotypes based on their asialoglycoprotein receptor-mediated adhesion to an artificial ligand, J. Artif. Organs, 4, 342, 10.1007/BF02480029 · doi:10.1007/bf02480029
- Yura, 2009, Coatings of low-density lipoprotein and synthetic glycoconjugates as substrata for hepatocytes, Artif. Organs, 33, 419, 10.1111/j.1525-1594.2009.00746.x · doi:10.1111/j.1525-1594.2009.00746.x
- Chernyy, 2013, Surface grafted glycopolymer brushes to enhance selective adhesion of HepG2 cells, J. Colloid Interface Sci., 404, 207, 10.1016/j.jcis.2013.04.025 · doi:10.1016/j.jcis.2013.04.025
- Matsuzaki, 1997, Hepatic lobar differences in progression of chronic liver disease: correlation of asialoglycoprotein scintigraphy and hepatic functional reserve, Hepatology, 25, 828, 10.1002/hep.510250407 · doi:10.1002/hep.510250407
- DiStefano, 2006, Doxorubicin coupled to lactosaminated albumin: enhanced drug levels in rat hepatocarcinomas, Dig. Liver Dis., 38, 2
- Dong, 2008, Galactosylated low molecular weight chitosan as a carrier delivering oligonucleotides to Kupffer cells instead of hepatocytes in vivo, J. Biomed. Mater. Res. A, 84, 777, 10.1002/jbm.a.31328 · doi:10.1002/jbm.a.31328
Cited by
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
The current state and future directions of RNAi-based therapeutics
Setten, R. L., Rossi, J. J., & Han, S.-P. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0017-4 · Cited by 1,443
Nanoparticle–liver interactions: Cellular uptake and hepatobiliary elimination
Zhang, Y.-N., Poon, W., Tavares, A. J., McGilvray, I. D., & Chan, W. C. W. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.020 · Cited by 1,349
The delivery of therapeutic oligonucleotides
Juliano, R. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw236 · Cited by 854
Crooke, S. T., Witztum, J. L., Bennett, C. F., & Baker, B. F. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.004 · Cited by 841
Metadata
- Authors
- D'Souza, A. A., & Devarajan, P. V.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 203
- Pages
- 126-139
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2052108548
- Cited by
- 621
- References
- 183
- FWCI
- 10.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.